Thus, our observations have the implication that sPD-L1 may be served as a potential biomarker for the diagnosis of CRC, together with other markers tested in currently clinical practices including CEA, CA19-9 and CA24-2 (14). The gene discussed is SPDL1; the disease is colorectal carcinoma.